Wednesday, September 23, 2026

Evertec, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Evertec, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. Exelixis, Inc.

11% sales growth and 6.27% return on equity

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States.

Exelixis, Inc.'s sales growth this year is expected to be 22.9% and 32.3% for next year.

Year-on-year quarterly revenue growth grew by 12.4%, now sitting on 987.54M for the twelve trailing months.

Exelixis, Inc.'s sales growth for the next quarter is 11%. The company's growth estimates for the ongoing quarter and the next is a negative 73.3% and negative -66.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.27%.

Volatility

Exelixis, Inc.'s last day, last week, and last month's current volatility was 1.69%, 0.75%, and 1.84%, respectively.

Exelixis, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.26% (day), 2.60% (last week), and 3.57% (last month), respectively.

Exelixis, Inc.'s Stock Yearly Top and Bottom Value

Exelixis, Inc.'s stock is valued at $24.10 at 14:22 EST, way below its 52-week high of $27.80 and way above its 52-week low of $18.08.

Exelixis, Inc.'s Moving Average

Exelixis, Inc.'s value is above its 50-day moving average of $22.67 and way above its 200-day moving average of $21.88.

3. Sensata Technologies Holding N.V. Ordinary Shares

58.8% sales growth and 6.22% return on equity

Sensata Technologies Holding plc, through its subsidiaries, develops, manufactures, and sells sensors, sensor-based solutions, controls, and other products in the Americas, Europe, Asia, and internationally.

Sensata Technologies Holding N.V. Ordinary Shares's sales growth this year is anticipated to be 17.4% and 6.7% for next year.

Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 3.05B for the twelve trailing months.

Sensata Technologies Holding N.V. Ordinary Shares's sales growth for the next quarter is 58.8%. The company's growth estimates for the current quarter and the next is 37.7% and 361.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.22%.

Volatility

Sensata Technologies Holding N.V. Ordinary Shares's last day, last week, and last month's current volatility was 0.17%, 0.97%, and 1.41%, respectively.

Sensata Technologies Holding N.V. Ordinary Shares's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.42% (day), 2.24% (last week), and 2.73% (last month), respectively.

Sensata Technologies Holding N.V. Ordinary Shares's Stock Yearly Top and Bottom Value

Sensata Technologies Holding N.V. Ordinary Shares's stock is valued at $57.81 at 14:22 EST, way below its 52-week high of $64.80 and way above its 52-week low of $29.82.

Sensata Technologies Holding N.V. Ordinary Shares's Moving Average

Sensata Technologies Holding N.V. Ordinary Shares's value is under its 50-day moving average of $59.79 and way higher than its 200-day moving average of $52.09.

4. TTEC Holdings, Inc.

17.1% sales growth and 26.09% return on equity

TTEC Holdings, Inc., a customer experience technology and services company, focuses on the design, implementation, and delivery of transformative customer experience for various brands.

TTEC Holdings, Inc.'s sales growth this year is expected to be 11.4% and 8.7% for next year.

Year-on-year quarterly revenue growth grew by 23.8%, now sitting on 1.95B for the twelve trailing months.

TTEC Holdings, Inc.'s sales growth for the next quarter is 17.1%. The company's growth estimates for the ongoing quarter and the next is 57.8% and 33.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.09%.

Volatility

TTEC Holdings, Inc.'s last day, last week, and last month's current volatility was 1.04%, 1.51%, and 2.14%, respectively.

TTEC Holdings, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.61% (day), 3.06% (last week), and 3.79% (last month), respectively.

TTEC Holdings, Inc.'s Stock Yearly Top and Bottom Value

TTEC Holdings, Inc.'s stock is valued at $108.75 at 14:22 EST, below its 52-week high of $109.53 and way higher than its 52-week low of $33.42.

TTEC Holdings, Inc.'s Moving Average

TTEC Holdings, Inc.'s worth is way above its 50-day moving average of $89.96 and way higher than its 200-day moving average of $73.41.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com